Year
----------- -----------
2008 2007 2008 2007
---- ---- ---- ----
Home Health $0.1 $0.1 $0.4 $0.6
Other Related Services - - - 0.1
Corporate expenses 0.5 0.2 2.3 1.7
--- --- --- ---
Total $0.6 $0.3 $2.7 $2.4
==== ==== ==== ====
4) Operating contribution for CareCentrix was comprised of the following
(dollars in thousands):
4th Quarter Fiscal Year
----------- -----------
2008 2007 2008 2007
---- ---- ---- ----
Gross profit $- $15,134 $42,539 $59,100
Selling, general and
administrative
expenses - (8,080) (24,850) (30,524)
Add: depreciation - 126 385 494
--- --- --- ---
Operating Contribution $- $7,180 $18,074 $29,070
==== ====== ======= =======
5) Commercial Insurance and Other revenues included revenues paid on an
episodic basis of $14.5 million and $53.2 million for the fourth
quarter and fiscal year 2008, respectively, and $9.0 million and
$29.3 million for the fourth quarter and fiscal year 2007,
respectively, reflecting services rendered to Medicare beneficiaries
enrolled in managed Medicare plans.
6) The Company's effective tax rate was 41.6% for the fourth quarter and
16.1% for fiscal year 2008, and 37.4% and 40.9% for the fourth
quarter and fiscal year 2007, respectively. Duri
'/>"/>SOURCE Gentiva Health Services, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Related biology technology :1.
Gentiva Reports Strong Second Quarter led by Home Health Segment2.
Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix3.
EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound4.
QMed, Inc. Reports July Medicare SNP Enrollments5.
Phlo Affiliate Reports Expanded Coverage to Oregon Border6.
Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results7.
Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 20078.
Carrington Reports Second Quarter 2007 Results9.
Avitar Reports Third Quarter Financial Results for Fiscal 200710.
Response Genetics Reports Second Quarter 2007 Financial Results11.
Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results